IBD News

New recommendations for IBD patient during the COVID-19 Pandemic

Summarized from the International Organization for the Study of Inflammatory Bowel Disease
​View Full Article

  • IBD patients do not seem to be at any increased risk of contracting the coronavirus that causes COVID-19 pandemic, compared to people without IBD.
  • In general, it is recommended in patients who are asymptomatic and at lower risk for COVID-19, to continue their current medications for IBD. The exception to this is of prednisone (see below).
  • Taking prednisone at doses of greater than 20mg daily may be linked to a higher risk of contracting and having more serious infection with COVID-19. Speak to your doctor right away if you can taper off these medications (do not discontinue yourself as this can be dangerous to do so)
  • If you do develop COVID-19 infection, certain IBD medications including certain biologic drugs (injections/infusions) may need to be held for at least 14 days or until you recover and/or test negative for the corona virus. Speak to your gastroenterologist immediately if you do test positive or develop symptoms of a cough, fever, sore throat or shortness of breath.

Events

What is Ulcerative Colitis and Crohn's Disease?

March 23, 2021 at 4 p.m.

Join Caroline Hwang, M.D. gastroenterologist and Director of Hoag's Margolis Family Inflammatory Bowel Disease Program as she discussed the signs and diagnosis of ulcerative colitis and Crohn's disease. Register Online

COVID-19 Notice: For the safety of our community, we are only offering live streaming and virtual classes at this time.

Contact Us at 888-522-0014
*Please note: This is an information line only. Should you need to speak directly to your physician's office regarding your healthcare issue or an appointment, please call your physician's office directly.